The Akzo Nobel N.V. (AKZOF) SEC filings page on Stock Titan is intended to provide access to regulatory documents and disclosures associated with the company’s listing. While no SEC filings are currently available in the provided data, this page is structured to capture submissions from the U.S. Securities and Exchange Commission’s EDGAR system whenever they are filed.
For a company linked to AkzoNobel, a global paints and coatings business in the specialty chemicals industry, formal filings can be an important source of information about its structure and activities. When available, investors typically review annual reports on Form 20-F or 10-K equivalents, interim reports, and other disclosures to better understand segment performance, risk factors and major corporate developments.
On Stock Titan, new filings for AKZOF would appear with real-time updates from EDGAR. AI-powered summaries are used to explain the key points in each document in more accessible language, helping readers interpret complex sections and identify the most relevant information without reading every page in detail.
In addition to annual and periodic reports, this page is designed to surface other important filing types when they exist, such as registration statements or disclosures of significant events. Insider transaction reports on Form 4 and proxy or equivalent materials on executive compensation would also be highlighted if they become available, with AI-generated insights to clarify their implications. Together, these tools aim to make any future AKZOF regulatory filings easier to review and compare.
Akzo Nobel N.V. reported Q3 2026 revenue of €2.538 billion versus €2.547 billion in Q3 2025; it described revenue as flat and comparable organic sales growth as 2%, driven by pricing. Adjusted EBITDA was €388 million, up 1% reported and 4% comparable from €385 million; its margin was 15.3% versus 15.1%, a sixth consecutive quarter of expansion.
Net cash from operating activities was €187 million, compared with €331 million a year earlier. Operating income was a loss of €73 million versus a loss of €29 million, with AkzoNobel citing Russia deconsolidation and the Pakistan divestment as impacts. The company signed binding agreements to sell Deco Paints South East Asia for $1.35 billion, at 21x FY25 EBITDA.
Based on current market visibility and prevailing trading conditions, and subject to ongoing market uncertainties, AkzoNobel expects around €100 million of adjusted EBITDA improvement in constant currencies and around €1.47 billion of adjusted EBITDA for full-year 2026. The latter is based on year-end 2025 exchange rates and adjusted for divestments of its liquid coatings businesses in Asia. The standalone outlook excludes the proposed Axalta merger, whose closing is expected in early 2027, subject to regulatory approvals.
Akzo Nobel N.V. reported Q3 2026 revenue flat year over year, with 2% organic sales growth and adjusted EBITDA of €388 million versus €385 million. Operating income was negative €73 million versus negative €29 million; Q3 2026 was impacted by the €230 million Russia deconsolidation loss, the €46 million Pakistan divestment loss, and costs in anticipation of the merger.
For January–September 2026, revenue was €7.513 billion versus €7.786 billion, adjusted EBITDA was €1.131 billion versus €1.135 billion, and net income attributable to shareholders was €54 million versus €37 million. Net debt was €3.090 billion at September 30, 2026, versus €2.942 billion at December 31, 2025.
AkzoNobel signed agreements to sell Deco South East Asia to Nippon Paint for approximately $1.35 billion (€1.20 billion) enterprise value; expected net cash proceeds after taxes and non-controlling interests are approximately $1 billion (€0.9 billion). The sale is subject to customary closing conditions; Indonesia is expected to close in late 2026 and the other sales in mid-2027. Both shareholder groups approved the proposed all-stock Axalta merger; closing is expected in early 2027, subject to regulatory approvals and other conditions.
Akzo Nobel N.V. reported Q3 2026 revenue of €2,538 million, described as flat year over year, with 2% organic sales growth driven by pricing. Adjusted EBITDA was €388 million versus €385 million, and adjusted EBITDA margin was 15.3% versus 15.1%. Operating income was negative €73 million, reflecting €230 million from the Russia deconsolidation, €46 million from the Pakistan divestment and costs in anticipation of the Axalta merger. Net cash from operating activities was €187 million versus €331 million.
For full-year 2026, AkzoNobel expects around €1.47 billion in adjusted EBITDA and around €100 million of adjusted EBITDA improvement in constant currencies, based on current market visibility and prevailing trading conditions. The outlook is on a standalone basis and adjusted for divestment of liquid coatings businesses in Asia. Binding agreements to sell Decorative Paints South East Asia to Nippon Paint are subject to customary closing conditions, including regulatory approvals; completion is expected in mid-2027, except for Indonesia, expected in late 2026. The Axalta merger, subject to regulatory approvals, is expected to close in early 2027.
Akzo Nobel N.V. (AKZOF) announced an Extraordinary General Meeting for November 30, 2026, with proposals relating to the planned all-share merger of equals with Axalta Coating Systems Ltd. The agenda includes amending the combined company’s articles of association to reflect the proposed name Axanzo N.V.; AXZ is the envisaged post-closing ticker symbol.
Shareholders will also consider appointing Denise Johnson, Stephan Tanda and Robert Schuchna as non-executive directors of the combined company. They have agreed to serve following completion of the merger.
Akzo Nobel N.V. and Axalta Coating Systems announced that the combined company will be called Axanzo following completion of their intended merger. The post-closing ticker is envisaged as AXZ on the NYSE and Euronext Amsterdam. AkzoNobel CEO Greg Poux-Guillaume is to lead the combined company, with Axalta CEO Chris Villavarayan as deputy CEO.
The combined business is described as bringing together around 100 brands across more than 160 countries. Closing is expected in early 2027 once all regulatory approvals and customary closing conditions have been finalized; the companies will operate independently until closing. The name announcement does not change how customers and partners currently work with either company.
Akzo Nobel N.V. (AKZOF) has entered into binding agreements to sell its Decorative Paints business in Southeast Asia to Nippon Paint for a total enterprise value of approximately $1.35 billion (€1.20 billion). The transactions represent an EV/FY25 EBITDA multiple of 21x, and net cash proceeds after taxes and minority partners are expected to be approximately $1 billion (€0.9 billion). The business spans seven countries: Vietnam, Indonesia, Malaysia, Thailand, Singapore, Papua New Guinea and Australia. AkzoNobel will retain full ownership of its Coatings activities and Global Business Services organization.
Completion is expected in mid-2027, except for the Indonesia business, which is expected to complete separately in late 2026. The transactions are subject to customary closing conditions, including regulatory approvals. AkzoNobel said the planned divestments conclude its Decorative Paints portfolio review in Asia and that it will now focus on closing its merger with Axalta.
AKZO NOBEL NV (AKZOF) reports that AkzoNobel and Axalta Coating Systems Ltd. have agreed on three additional non-executive directors for the Board of their pending merger of equals. Stephan B. Tanda, Denise C. Johnson and Robert Schuchna have agreed to join the combined company’s Board upon completion of the transaction, with their appointments expected to be put forward for shareholder approval at an Extraordinary General Meeting later in 2026.
As outlined, the combined company Board at closing is expected to consist of Rakesh Sachdev (Chair), Ben Noteboom (Vice-Chair), Greg Poux‑Guillaume (CEO), Chris Villavarayan (Deputy CEO), Jaska de Bakker, Jan Bertsch, Denise Johnson, Wouter Kolk, Robert Schuchna, Kevin Stein and Stephan Tanda. The communication also reiterates that the merger remains subject to customary closing conditions and regulatory and shareholder processes, and refers investors to the effective Form F‑4 registration statement and Axalta’s definitive proxy statement for detailed information on the transaction.
Akzo Nobel N.V. reports that shareholders at an Extraordinary General Meeting on August 5, 2026 voted in favor of all resolutions related to the proposed all-share merger with Axalta Coating Systems Ltd. Approvals covered the merger itself, amendments to the Articles of Association, authorization to issue shares, board appointments and remuneration policy.
Axalta shareholders also backed the merger at a Special General Meeting, allowing the transaction to move to the next phase. Completion remains subject to required regulatory approvals and other customary closing conditions and is expected once these are satisfied at the end of 2026 or the beginning of 2027.
The communication states that investors should rely on AkzoNobel’s Form F-4 registration statement and Axalta’s definitive proxy statement/prospectus for detailed information, and it includes forward-looking statements language outlining risks such as failure to obtain approvals, integration challenges, business disruption and wider macroeconomic, public health and geopolitical uncertainties.
Akzo Nobel N.V. and Axalta Coating Systems Ltd. provide a supplement to their joint proxy statement/prospectus for the planned share-for-share merger, updating disclosures ahead of Axalta’s August 5, 2026 virtual special meeting. The supplement reflects a Second Amendment to the Merger Agreement and related joinder agreements that add Bermuda merger subsidiaries and refine post‑completion governance of the combined company, including detailed rules for the MergeCo board’s composition, director terms and voting thresholds, with many super‑majority requirements reduced from 75% to two thirds of non‑executive directors.
Axalta also discloses shareholder lawsuits and demand letters alleging disclosure deficiencies; it states it believes these claims are without merit but is voluntarily providing additional detail to avoid expense and delay. The supplement describes Axalta’s engagement of Incentrum for a fee of $12.5 million and expands the summaries of Evercore’s and J.P. Morgan’s valuation work, including discounted cash flow methodologies, key assumptions and implied per‑share equity value ranges for both Axalta and AkzoNobel.
Akzo Nobel N.V. and Axalta Coating Systems Ltd. announced they have enhanced the proposed governance arrangements for the company that would be formed by their pending all-share merger of equals. The refinements follow extensive dialogue with shareholders and other stakeholders about the governance of the combined business, with the chairs of both boards emphasizing strong corporate governance and effective board oversight.
The governance enhancements do not require changes to the proposed Articles of Association of the combined company, so the AkzoNobel EGM and Axalta SGM scheduled for August 5, 2026 are proceeding with their existing agenda items. A registration statement on Form F-4, including Axalta’s proxy statement/prospectus for shares to be offered by AkzoNobel, was declared effective by the SEC on June 23, 2026, and Axalta filed a definitive proxy statement on June 24, 2026. Extensive risk and forward-looking statement disclosures outline conditions that could affect completion of the transaction, regulatory approvals, integration efforts, and broader economic and operational factors.